Literature DB >> 17534615

Bone and marrow imaging: do we know what we see and do we see what we want to know?

Giovanni Lucignani1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17534615     DOI： 10.1007/s00259-007-0473-7

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   10.057


× No keyword cloud information.
  9 in total

1.  Cancer stem cells and metastasis: lethal seeds.

Authors:  Max S Wicha
Journal:  Clin Cancer Res       Date:  2006-10-01       Impact factor: 12.531

2.  Bone marrow and not bone is the primary site for skeletal metastasis: critical role of [18F]fluorodeoxyglucose positron emission tomography in this setting.

Authors:  Sandip Basu; Abass Alavi
Journal:  J Clin Oncol       Date:  2007-04-01       Impact factor: 44.544

3.  A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

Authors:  Elena Zamagni; Cristina Nanni; Francesca Patriarca; Emanuela Englaro; Paolo Castellucci; Onelio Geatti; Patrizia Tosi; Paola Tacchetti; Delia Cangini; Giulia Perrone; Michela Ceccolini; Annamaria Brioli; Silvia Buttignol; Renato Fanin; Eugenio Salizzoni; Michele Baccarani; Stefano Fanti; Michele Cavo
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

4.  Multiple Myeloma: Molecular Imaging with 11C-Methionine PET/CT--Initial Experience.

Authors:  Anja Dankerl; Peter Liebisch; Gerhard Glatting; Claudia Friesen; Norbert M Blumstein; Darius Kocot; Christiane Wendl; Donald Bunjes; Sven N Reske
Journal:  Radiology       Date:  2006-12-19       Impact factor: 11.105

5.  MRI and (18)FDG-PET in the assessment of bone marrow infiltration of the spine in cancer patients.

Authors:  Nadir Alexander Ghanem; Gregor Pache; Christian Lohrmann; Ingo Brink; Thorsten Bley; Elmar Kotter; Thomas Kelly; Mathias Langer
Journal:  Eur Spine J       Date:  2007-04-03       Impact factor: 3.134

6.  Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast cancer predicts time to progression (TTP).

Authors:  Jennifer M Specht; Stephen L Tam; Brenda F Kurland; Julie R Gralow; Robert B Livingston; Hannah M Linden; Georgiana K Ellis; Erin K Schubert; Lisa K Dunnwald; David A Mankoff
Journal:  Breast Cancer Res Treat       Date:  2007-02-01       Impact factor: 4.872

7.  18F-fluorodeoxyglucose-positron emission tomography and bone scintigraphy for detecting bone metastases in patients with malignancies of the upper aerodigestive tract.

Authors:  Mi Ra Kim; Jong-Lyel Roh; Jae Seung Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  Oral Oncol       Date:  2007-03-12       Impact factor: 5.337

8.  Detection of bone metastases: assessment of integrated FDG PET/CT imaging.

Authors:  Al V Taira; Robert J Herfkens; Sam S Gambhir; Andrew Quon
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

Review 9.  Structural and functional imaging of normal bone marrow and evaluation of its age-related changes.

Authors:  Judy S Blebea; Mohamed Houseni; Drew A Torigian; Chengzhong Fan; Ayse Mavi; Ying Zhuge; Tad Iwanaga; Shipra Mishra; Jay Udupa; Jiyuan Zhuang; Rohit Gopal; Abass Alavi
Journal:  Semin Nucl Med       Date:  2007-05       Impact factor: 4.446
  9 in total
  1 in total

1.  Evolving concept of imaging bone marrow metastasis in the twenty-first century: critical role of FDG-PET.

Authors:  Sandip Basu; Drew Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 10.057
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.